You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
NEW YORK— Biomarker test developer Biovica has filed a 501(k) submission with the US Food and Drug Administration for its DiviTum assay for monitoring breast cancer treatment response.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.
Last year, by Precision Oncology News' count, the FDA approved 27 precision oncology drugs, a 35 percent increase in the number of approvals from 2019.